Caregiving in a time of Coronavirus

A message from your Alzheimer’s Disease Research Center

University of Pittsburgh

Alzheimer’s Disease Research Center

The University of Pittsburgh Alzheimer’s Disease Research Center (ADRC) is one of the nation’s leading research centers specializing in the diagnosis of Alzheimer’s disease and related disorders.

Memory Evaluation

Donate Now

Effect of COVID-19 on Alzheimer’s Clinical Research & the Needs of Patients & Their Caregivers

In this video Dr. Oscar Lopez provides an update on how patient care is being approached at UPMC during COVID-19 as well as the current state of clinical research at the Alzheimer’s Disease Research Center (ADRC).

Seeking individuals with Alzheimer’s disease who experience agitation

The Escitalopram for Agitation in Alzheimer's Disease (S-CitAD) study is a 12-week trial of escitalopram taking place at the University of Pittsburgh Alzheimer's Disease Research Center. The S-CitAD Study is looking for volunteers who: Have been diagnosed with...

WQED Documentary “Stolen Years” Highlights Research Being Conducted at the University of Pittsburgh ADRC

Nearly two-thirds of Americans living with Alzheimer’s are women. Sixty percent of all Alzheimer’s caregivers are women.

BRiTE Wellness Program aims to help seniors with mild memory problems

The BRiTE (Brain Training and Exercise) Center mission is to promote the overall health and wellness of older adults who want to optimize their level of cognitive, social, and physical functioning.

Upcoming Events

There are no upcoming events at this time.

The University of Pittsburgh Alzheimer’s Disease Research Center (ADRC) is one of the nation’s leading research centers specializing in the diagnosis of Alzheimer’s disease and related disorders. Through outpatient evaluations, participants and their families receive state-of-the-art diagnostic assessments and contribute to the scientific study of Alzheimer’s disease.

ADRC Memory Evaluation and Participation in the Research Center

George has been participating since 2017

Talking to somebody about joining a study, they might think, ‘Hey, I don’t have Alzheimer’s,’ but the study doesn’t require that you do.


read more from George & other ADRC volunteers…

Our memory evaluation is an extensive diagnostic evaluation of individuals with suspected Alzheimer’s disease and other types of memory loss and/or cognitive impairment. The professionals at the ADRC understand that this is a stressful process for all and assure that individuals will be treated with sensitivity and respect.

Dementia with Lewy Bodies Consortium

Description: The purpose of this study is to collect clinical information, brain imaging scans, and biological samples from people that have dementia with Lewy bodies. This information will help researchers improve the diagnosis, care, and treatment of patients with this disease.

Study Length: 5 years

Study Requirements:
Age 40-90
Diagnosis of Lewy Body Dementia (DLB) or high likelihood
A study partner who will accompany you to all study visits

Contact:
Donna Simpson at 412-692-2717 or simpsondm@upmc.edu or
MaryAnn Oakley at 412-692-2721 or oakleym@upmc.edu

Alzheimer’s Disease Neuroimaging Initiative – 3 (ADNI3)

Description: The overall goal is to determine the relationships among the clinical, cognitive, imaging, genetic and biochemical biomarker characteristics of the entire spectrum of Alzheimer’s disease (AD) from its earliest stages. Subjects will undergo longitudinal clinical and cognitive assessments, computerized cognitive batteries, biomarker and genetic tests, PET (FDG, amyloid and tau) and MRI scans and cerebral spinal fluid (CSF) collection. For more information about the ADNI3 study visit http://www.adni-info.org

Study Length: up to 5 years

Study Requirements:
55-90 years of age
Cognitively normal; or have Mild Cognitive Impairment (MCI); or have been diagnosed with Alzheimer’s disease
A study partner who will accompany you to all study visits

Contact:
MaryAnn Oakley at 412-692-2721 or oakleym@upmc.edu

Escitalopram for Agitation in Alzheimer’s Disease (S-CitAD)

Description: The study is designed to examine the efficacy and safety of escitalopram in combination with a psychosocial intervention (PSI) as treatment for agitation in AD patients.

Study Length: 6 months

Study Requirements:
Diagnosis of Alzheimer’s disease with significant agitation/aggression
A study partner who will accompany you to all study visits

Contact:
Patricia Henderson 412-692-2703 or hendersonpl@upmc.edu 

FORAging – Facilitating Optimal Routines in Aging

Description: This study is looking at ways to minimize problems with everyday tasks by using a new strategy.

Study Length: 12 months

Study Requirements:
60 years of age AND
Having difficulty managing daily tasks

Contact:
MaryAnn Oakley at 412-692-2721 or oakleym@upmc.edu

ADRC Video Spotlight

Follow Doris to see what it is like for those who get involved at the University of Pittsburgh Alzheimer Disease Research Center.

Pathways Newsletter

The Summer 2020 edition of the Pathways Newsletter is now available.